These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34528179)

  • 1. The Two Faces of Estrogen in Experimental Hemorrhagic Stroke.
    Koduri S; Keep RF; Hua Y; Chaudhary N; Pandey AS; Xi G
    Transl Stroke Res; 2022 Jun; 13(3):362-363. PubMed ID: 34528179
    [No Abstract]   [Full Text] [Related]  

  • 2. [Some features of the postmortal diagnosis of hemorrhagic strokes as a type of cerebrovascular disease].
    Machinsky PA; Plotnikova NA; Uliankin VE; Kemaikin SP; Rybakov AG
    Sud Med Ekspert; 2021; 64(1):51-56. PubMed ID: 33511836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of hemorrhage in ischemic stroke and its relationship with cerebral microbleeds.
    Ozbek D; Ozturk Tan O; Ekinci G; Midi I
    Clin Neurol Neurosurg; 2018 May; 168():112-117. PubMed ID: 29549810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep Transfer Learning for Automatic Prediction of Hemorrhagic Stroke on CT Images.
    Rao BN; Mohanty S; Sen K; Acharya UR; Cheong KH; Sabut S
    Comput Math Methods Med; 2022; 2022():3560507. PubMed ID: 35469220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke.
    Natsuaki M; Morimoto T; Watanabe H; Nakagawa Y; Furukawa Y; Kadota K; Akasaka T; Hanaoka KI; Kozuma K; Tanabe K; Morino Y; Muramatsu T; Kimura T;
    J Am Heart Assoc; 2019 Nov; 8(22):e013356. PubMed ID: 31701821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal Hemorrhagic Stroke.
    Amlie-Lefond C; Ojemann JG
    JAMA Pediatr; 2017 Mar; 171(3):220-221. PubMed ID: 28114635
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebral Microbleeds Meta-analyses of Prospective Studies: The Need to Consider Both Ischemic and Hemorrhagic Stroke Outcomes.
    Charidimou A
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):1007. PubMed ID: 26794263
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk factors for stroke recurrence in patients with hemorrhagic stroke.
    Wong YS; Tsai CF; Ong CT
    Sci Rep; 2022 Oct; 12(1):17151. PubMed ID: 36229641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage: Subgroup Analysis of the PICASSO Trial.
    Kim BJ; Kwon SU; Park JH; Kim YJ; Hong KS; Wong LKS; Yu S; Hwang YH; Lee JS; Lee J; Rha JH; Heo SH; Ahn SH; Seo WK; Park JM; Lee JH; Kwon JH; Sohn SI; Jung JM; Navarro JC; Kim HY; Kim EG; Kim S; Cha JK; Park MS; Nam HS; Kang DW;
    Stroke; 2020 Mar; 51(3):931-937. PubMed ID: 31856691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The physiopathology of spontaneous hemorrhagic stroke: a systematic review.
    Morais Filho AB; Rego TLH; Mendonça LL; Almeida SS; Nóbrega MLD; Palmieri TO; Giustina GZD; Melo JP; Pinheiro FI; Guzen FP
    Rev Neurosci; 2021 Aug; 32(6):631-658. PubMed ID: 33594841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain hemorrhage on 24h-CT and functional outcome in stroke patients with cerebral amyloid angiopathy features on pre-thrombolysis MRI treated with intravenous thrombolysis: A case series.
    Leonte A; Laurent-Chabalier S; Wacongne A; Parvu T; Hackius M; Thouvenot E; Renard D
    J Stroke Cerebrovasc Dis; 2023 Feb; 32(2):106907. PubMed ID: 36442282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trial.
    Naidech AM; Grotta J; Elm J; Janis S; Dowlatshahi D; Toyoda K; Steiner T; Mayer SA; Khanolkar P; Denlinger J; Audebert HJ; Molina C; Khatri P; Sprigg N; Vagal A; Broderick JP
    Int J Stroke; 2022 Aug; 17(7):806-809. PubMed ID: 34427473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors and outcomes of hemorrhagic stroke in reversible cerebral vasoconstriction syndrome.
    Garg A; Rocha M; Starr M; Ortega-Gutierrez S
    J Neurol Sci; 2021 Feb; 421():117312. PubMed ID: 33454590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke Care and Application of Thrombolysis in Ibero-America: Report From the SITS-SIECV Ibero-American Stroke Register.
    Alonso de Leciñana M; Mazya MV; Kostulas N; Del Brutto OH; Abanto C; Massaro AR; de Bastos M; Martins S; Ameriso SF; Gongora-Rivera F; Sacks C; Hoppe A; Abad P; Meza G; Arauz-Gongora A; Wahlgren N; Díez-Tejedor E;
    Stroke; 2019 Sep; 50(9):2507–2512. PubMed ID: 31670921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral small vessel disease and intracranial bleeding risk: Prognostic and practical significance.
    Best JG; Jesuthasan A; Werring DJ
    Int J Stroke; 2023 Jan; 18(1):44-52. PubMed ID: 35658630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Andexanet-Alfa-Associated Heparin Resistance in the Context of Hemorrhagic Stroke.
    Müther M; Schwindt W; Mesters RM; Minnerup J; Stracke P; Holling M; Wiendl H; Stummer W
    Neurocrit Care; 2022 Oct; 37(2):372-376. PubMed ID: 35931915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of admission neutrophil/lymphocyte ratio in symptomatic intracranial hemorrhage after stroke thrombolysis.
    Ören O; Haki C; Kaya H; Yüksel M
    Neurol Sci; 2022 Jan; 43(1):435-440. PubMed ID: 34018076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in AQP Research and New Developments in Therapeutic Approaches to Ischemic and Hemorrhagic Stroke.
    Previch LE; Ma L; Wright JC; Singh S; Geng X; Ding Y
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27438832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemorrhagic transformation in patients with acute ischaemic stroke and an indication for anticoagulation.
    Marsh EB; Llinas RH; Hillis AE; Gottesman RF
    Eur J Neurol; 2013 Jun; 20(6):962-7. PubMed ID: 23521544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of active fraction of cerebral on expression of caspase-3 and beta-amyloid precursor protein during therapy of hemorrhagic stroke in the acute and delayed periods.
    Makarenko AN; Vasil'eva IG; Chopik NG; Galanta ES; Tsyubko OI; Oleksenko NP
    Bull Exp Biol Med; 2005 Feb; 139(2):207-9. PubMed ID: 16027808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.